secwatch.observer — SEC 8-K summary
======================================

Issuer:     ULTRALIFE CORP (ULBI)
CIK:        0000875657
Form:       8-K
Filed at:   2022-07-21T23:59:59+00:00
Accession:  0001437749-22-017510
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Ultralife shareholders elect all five directors, ratify auditor at 2022 annual meeting
--------------------------------------------------------------------------------

- All five director nominees elected with majority support; Ranjit C. Singh received 9.8M for vs 1.6M withheld.
- Ratification of Freed Maxick CPAs as independent auditor approved: 13.66M for vs 15.8K against.
- Quorum of 85% of outstanding shares (13.7M of 16.1M) present at July 20, 2022 meeting.
- Directors elected to one-year terms until 2023 annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/875657/000143774922017510/0001437749-22-017510-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/875657/000143774922017510/ulbi20220721_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-22-017510

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer